Universe Pharmaceuticals Stock Performance
| UPC Stock | USD 1.78 0.06 3.49% |
The entity has a beta of 0.23, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Universe Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Universe Pharmaceuticals is expected to be smaller as well. At this point, Universe Pharmaceuticals has a negative expected return of -3.74%. Please make sure to validate Universe Pharmaceuticals' accumulation distribution, and the relationship between the value at risk and day typical price , to decide if Universe Pharmaceuticals performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Universe Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Last Split Factor 1:15 | Last Split Date 2024-11-18 |
1 | Universe Pharmaceuticals GAAP EPS of -3.59, revenue of 12.88M | 09/20/2024 |
2 | UPCX Self Reported Market Capitalization Reaches 1.32 Million | 10/22/2024 |
3 | UPCX Hits 24 Hour Volume of 1.79 Million | 10/28/2024 |
4 | Universe Pharmaceuticals receives non-compliance letter from Nasdaq | 11/01/2024 |
5 | UPCX Trading Down 2.3 percent Over Last 7 Days | 11/06/2024 |
6 | Universe Pharmaceuticals Inc trading halted, news pending - TipRanks | 11/15/2024 |
7 | Universe Pharmaceuticals stock hits 52-week low at 1.78 By Investing.com - Investing.com Australia | 11/21/2024 |
| Begin Period Cash Flow | 5.7 M |
Universe |
Universe Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 4,485 in Universe Pharmaceuticals on September 2, 2024 and sell it today you would lose (4,307) from holding Universe Pharmaceuticals or give up 96.03% of portfolio value over 90 days. Universe Pharmaceuticals is generating negative expected returns assuming volatility of 12.8595% on return distribution over 90 days investment horizon. In other words, majority of equities are less volatile than Universe, and most equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Universe Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Universe Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Universe Pharmaceuticals, and traders can use it to determine the average amount a Universe Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2906
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | UPC |
Estimated Market Risk
| 12.86 actual daily | 96 96% of assets are less volatile |
Expected Return
| -3.74 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.29 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Universe Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Universe Pharmaceuticals by adding Universe Pharmaceuticals to a well-diversified portfolio.
Universe Pharmaceuticals Fundamentals Growth
Universe Stock prices reflect investors' perceptions of the future prospects and financial health of Universe Pharmaceuticals, and Universe Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Universe Stock performance.
| Return On Equity | -0.5 | ||||
| Return On Asset | -0.0565 | ||||
| Profit Margin | (0.69) % | ||||
| Operating Margin | (0.14) % | ||||
| Current Valuation | (2.07 M) | ||||
| Shares Outstanding | 1.58 M | ||||
| Price To Earning | 3.02 X | ||||
| Price To Book | 0.10 X | ||||
| Price To Sales | 0.10 X | ||||
| Revenue | 32.31 M | ||||
| Gross Profit | 21.89 M | ||||
| EBITDA | (3.22 M) | ||||
| Net Income | (6.16 M) | ||||
| Cash And Equivalents | 28.58 M | ||||
| Cash Per Share | 1.31 X | ||||
| Total Debt | 5.48 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 5.06 X | ||||
| Book Value Per Share | 7.33 X | ||||
| Cash Flow From Operations | 1.12 M | ||||
| Earnings Per Share | (76.35) X | ||||
| Market Capitalization | 2.81 M | ||||
| Total Asset | 53.29 M | ||||
| Retained Earnings | 10.16 M | ||||
| Working Capital | 23.06 M | ||||
About Universe Pharmaceuticals Performance
By analyzing Universe Pharmaceuticals' fundamental ratios, stakeholders can gain valuable insights into Universe Pharmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Universe Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Universe Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 63.81 | 78.01 | |
| Return On Tangible Assets | (0.12) | (0.13) | |
| Return On Capital Employed | (0.10) | (0.10) | |
| Return On Assets | (0.12) | (0.13) | |
| Return On Equity | (0.18) | (0.17) |
Things to note about Universe Pharmaceuticals performance evaluation
Checking the ongoing alerts about Universe Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Universe Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Universe Pharmaceuticals generated a negative expected return over the last 90 days | |
| Universe Pharmaceuticals has high historical volatility and very poor performance | |
| Universe Pharmaceuticals may become a speculative penny stock | |
| Universe Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the last year's revenue of 32.31 M. Reported Net Loss for the year was (6.16 M) with profit before taxes, overhead, and interest of 21.89 M. | |
| Latest headline from news.google.com: Universe Pharmaceuticals stock hits 52-week low at 1.78 By Investing.com - Investing.com Australia |
- Analyzing Universe Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Universe Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Universe Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Universe Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Universe Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Universe Pharmaceuticals' stock. These opinions can provide insight into Universe Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Universe Stock analysis
When running Universe Pharmaceuticals' price analysis, check to measure Universe Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universe Pharmaceuticals is operating at the current time. Most of Universe Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Universe Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universe Pharmaceuticals' price. Additionally, you may evaluate how the addition of Universe Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |